• Medicine pricing policy: Drug prices cannot be raised during market disruptions due to sector regulations, making continuous product availability the primary priority.
• Supply chain disruptions: Upstream oil and gas shortages are expected to trigger severe material deficits within two months, impacting essential chemicals, acids, packaging bottles, and solvents needed for label printing.
• Shipping capacity constraints: Even if energy flows normalize, an acute deficit of containers and boats to transport backlogged inventory will turn the situation into a long-drawn crisis.
• Global market reliance: Ensuring uninterrupted medicine supplies is critical for global healthcare, as India manufactures 60% of all medicines consumed in the US as well as supplies for other major markets.